Substance-induced mental disorders and discontinuation of medication for opioid use disorder

This publication has 48 references indexed in Scilit:

• Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic
  JAMA Network Open, 2022
• Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
  JAMA Network Open, 2022
• Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
  JAMA Health Forum, 2022
• The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings
  Social Psychiatry and Psychiatric Epidemiology, 2015
• Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses
  Addictive Behaviors, 2014
• Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users
  JAMA Psychiatry, 2013
• EFFECT OF CONCURRENT SUBSTANCE USE DISORDER ON THE EFFECTIVENESS OF SINGLE AND COMBINATION ANTIDEPRESSANT MEDICATIONS FOR THE TREATMENT OF MAJOR DEPRESSION: AN EXPLORATORY ANALYSIS OF A SINGLE-BLIND RANDOMIZED TRIAL
  Depression and Anxiety, 2012
• Discrepancy in Diagnosis and Treatment of Post-traumatic Stress Disorder (PTSD): Treatment for the Wrong Reason
  The Journal of Behavioral Health Services & Research, 2011
• Prevalence and Co-occurrence of Substance Use Disorders and IndependentMood and Anxiety Disorders
  Archives of General Psychiatry, 2004
• The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample
  Drug and Alcohol Dependence, 1995